Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 19, 2022
Recro Pharma, Inc. announced the appointment of Eduardo Uribe as the company’s head of quality for Recro San Diego. Mr. Uribe has more than 30 years of experience developing, implementing and managing quality systems within the biotechnology and ...
read more
Monday, November 01, 2021
Recro Pharma, a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, announced the signing of a master supply and ...
read more
Recro Pharma, Inc. announced that it is changing its name to Societal CDMO, Inc. to reflect the corporate transformation that has taken place primarily as a result of its acquisition and successful integration of IriSys, Inc. into the organization.
read more
Wednesday, February 17, 2021
Recro Pharma has announced key appointments to its management team and board of directors.
read more
Wednesday, September 08, 2021
Recro Pharma, Inc. a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges in small molecule therapeutic development, and BioCorRx, a developer and provider of advanced ...
read more
With its acquisition of IRISYS, Recro has transformed itself into a full-service CDMO with operations on both the East and West Coast of the U.S. capable of offering its now expanded global client base access to services spanning from pre-...
read more
Wednesday, October 21, 2020
Recombinetics has partnered with American Preclinical Services in a first of its kind study to improve Glioblastoma outcomes.
read more
U-Protein Express announced the availability of its new recombinant SARS-CoV-2 proteins, and other proteins associated with COVID-19, for use by researchers globally.
read more
Recipharm announced an exclusive licence and collaboration agreement with Medspray and Resyca, to develop soft mist nasal delivery devices for single and combination drug products.
read more
Recipharm and LIDDS have set up a manufacturing line for LIDDS’ novel prostate cancer drug, Liproca Depot, at Recipharm in Solna, Sweden.
read more
Thursday, September 14, 2017
Recipharm and Kancera have signed a contract for the development and manufacture of the pharmaceutical candidate KAND567.
read more
Recipharm has partnered with Hadasit Medical Research Services and Development to offer combined clinical, biological and chemical services.
read more
Tuesday, September 12, 2017
Recipharm and Clinical Trial Consultants have partnered to launch a new service that delivers a clear, streamlined pathway to first in human milestones.
read more
Wednesday, November 13, 2019
Recipharm and CTC Clinical Trial Consultants have expanded their partnership with the divestment of Recipharm’s GLP bioanalysis business to the Center for Translational Research group.
read more
Recipharm has signed a licensing agreement with Altus Formulation to allow its customers to access new drug delivery technologies and products.
read more